Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients by Favoring the Recruitment of Effector T Cell Subsets

Increasing evidence strongly suggests that bevacizumab compound impacts the immunological signature of cancer patients and normalizes tumor vasculature. This study aims to investigate the correlation between the clinical response to bevacizumab-based chemotherapy and the improvement of immune fitnes...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Clin Med
Prif Awduron: Napoletano, Chiara, Ruscito, Ilary, Bellati, Filippo, Zizzari, Ilaria Grazia, Rahimi, Hassan, Gasparri, Maria Luisa, Antonilli, Morena, Panici, Pierluigi Benedetti, Rughetti, Aurelia, Nuti, Marianna
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2019
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6462947/
https://ncbi.nlm.nih.gov/pubmed/30889935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8030380
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg